DOG1 expression in soft tissue tumors

International Journal of Surgical Pathology

Volumn 24, Issue 3, 2016, Pages 274-276

  Ng, Wen ^a   Lee, Jasmin ^a   Vroobel, Katherine ^a   Thway, Khin ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISCOVERED ON GASTROINTESTINAL STROMAL TUMOR 1; ION CHANNEL; TUMOR PROTEIN; UNCLASSIFIED DRUG; ANO1 PROTEIN, HUMAN; CHLORIDE CHANNEL; TUMOR MARKER;

CANCER PATIENT; CYTOPLASM; DIFFERENTIAL DIAGNOSIS; EWING SARCOMA; FIBROSARCOMA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; GLOMUS TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL CELL OF CAJAL; LETTER; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MYXOFIBROSARCOMA; MYXOSARCOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SARCOMA; SOFT TISSUE TUMOR; SYNOVIAL SARCOMA; BIOSYNTHESIS; METABOLISM; SOFT TISSUE NEOPLASMS;

BIOMARKERS, TUMOR; CHLORIDE CHANNELS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; SOFT TISSUE NEOPLASMS;

EID: 84964584484     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896915621967     Document Type: Letter

References (13)

1. West RB, Corless CL, Chen X, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol. 2004; 165: 107-113.
2. Gomez-Pinilla PJ, Gibbons SJ, Bardsley, et al. Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol. 2009; 296: G1370-G1381.
3. Hemminger J, Iwenofu OH,. Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (GIST) neoplasms. Histopathology. 2012; 61: 170-177.
4. Liegl B, Hornick JL, Corless CL, Fletcher CD,. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Am J Surg Pathol. 2009; 33: 437-446.
5. Espinosa I, Lee CH, Kim MK, et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol. 2008; 32: 210-218.
6. Rubin BP, Heinrich MC,. Genotyping and immunohistochemistry of gastrointestinal stromal tumors: an update. Semin Diagn Pathol. 2015; 32: 392-399.
7. Miettinen M, Wang ZF, Lasota J,. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol. 2009; 33: 1401-1408.
8. Thway K, Ng W, Benson C, Chapman J, Fisher C,. DOG1 expression in low-grade fibromyxoid sarcoma: a study of 11 cases, with molecular characterization. Int J Surg Pathol. 2015; 23: 454-460.
9. Wong NA, Shelley-Fraser G,. Specificity of DOG1 (K9 clone) and protein kinase C theta (clone 27) as immunohistochemical markers of gastrointestinal stromal tumour. Histopathology. 2010; 57: 250-258.
10. Sah SP, McCluggage WG,. DOG1 immunoreactivity in uterine leiomyosarcomas. J Clin Pathol. 2013; 66: 40-43.
11. Novelli M, Rossi S, Rodriguez-Justo M, et al. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology. 2010; 57: 259-270.
12. Wong NA, Campbell F, Shepherd NA,. Abdominal monophasic synovial sarcoma is a morphological and immunohistochemical mimic of gastrointestinal stromal tumour. Histopathology. 2015; 66: 974-981.
13. Noujaim J, Thway K, Sheri A, Keller C, Jones RL,. Histology-driven therapy: the importance of diagnostic accuracy in guiding systemic therapy of soft tissue tumors. [published online 22, 2015 ]. Int J Surg Pathol. doi: 10.1177/1066896915606971.